Search Ontology:
ChEBI

nirmatrelvir

Term ID
CHEBI:170007
Synonyms
  • (1R,2S,5S)-N-{(1S)-1-cyano-2-[(3S)-2-oxopyrrolidin-3-yl]ethyl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide
  • nirmatrelvir
  • nirmatrelvirum
  • PF 07321332
  • PF-07321332
  • PF07321332
Definition
An azabicyclohexane that is (1R,5S)-3-azabicyclo[3.1.0]hexane substituted by {(1S)-1-cyano-2-[(3S)-2-oxopyrrolidin-3-yl]ethyl}aminoacyl, 3-methyl-N-(trifluoroacetyl)-L-valinamide, methyl and methyl groups at positions 2S, 3, 6 and 6, respectively. It is the first orally administered inhibitor of SARS-CoV-2 main protease developed by Pfizer and used in combination with ritonavir for the treatment of COVID-19.
References
  • cas:2628280-40-8
  • drugbank:DB16691
  • kegg.drug:D12244
  • pmc:PMC9232762
  • pmc:PMC9264725
  • pubmed:34687004
  • pubmed:35073029
  • pubmed:35153195
  • pubmed:35182772
  • pubmed:35183067
  • pubmed:35203821
  • pubmed:35305258
  • pubmed:35335157
  • pubmed:35389231
  • pubmed:35425393
  • pubmed:35461811
  • pubmed:35477935
  • pubmed:35505633
  • pubmed:35640480
  • pubmed:35678736
  • pubmed:35702394
  • pubmed:35845944
  • pubmed:36276807
  • pubmed:36574296
  • pubmed:36965419
  • pubmed:37074087
  • pubmed:37402789
  • pubmed:37510996
  • pubmed:37947496
  • pubmed:38257765
  • pubmed:38399271
  • pubmed:38432955
  • pubmed:38553607
  • wikipedia.en:Nirmatrelvir
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from nirmatrelvir
Phenotype where environments contain nirmatrelvir
Phenotype modified by environments containing nirmatrelvir
Phenotype affecting nirmatrelvir
Human Disease Model